Clinical Trials Directory

Trials / Completed

CompletedNCT02602496

Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals

Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals Through Intake of Whole Wheat Products in Comparison With Fruits and Vegetables

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
University of Nebraska Lincoln · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study evaluates the impact of increased intake of fruits and vegetables and whole grains on markers of inflammation and gut microbial composition. The treatment groups are 3 servings of whole grain per day; 5 servings of fruits and vegetables per day; and a control (3 servings of refined grains per day provided).

Detailed description

Literature data suggests that fruits and vegetables and whole grains containing dietary fiber and other nutrients are important for maintaining beneficial microbes in the gut. The presence of beneficial microbes in the gut may mediate the subclinical inflammation experienced in metabolic disease. In this project, overweight or obese participants with low intakes of fruits and vegetables or whole grains will increase their intake of these foods to recommended levels. Changes in markers of inflammation and gut microbiota composition will be determined to assess and compare the potential impact of these foods on metabolic disease.

Conditions

Interventions

TypeNameDescription
OTHERFruits and Vegetables5 servings of fruits or vegetables
OTHERWhole Grain3 servings of whole grain
OTHERControl3 servings of refined grain

Timeline

Start date
2015-10-01
Primary completion
2017-06-01
Completion
2017-07-01
First posted
2015-11-11
Last updated
2019-06-05
Results posted
2019-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02602496. Inclusion in this directory is not an endorsement.

Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals (NCT02602496) · Clinical Trials Directory